Skip to main content
. 2017 Oct 10;28:122. doi: 10.11604/pamj.2017.28.122.12611

Table 3.

Bivariate analysis of factors that influence the uptake of SP

SP Doses
Sub Optimal (≤2 doses) Optimal(≥3 doses) P value
Age 0.20
<30 years 56(25.0) 168(75.0)
≥30 years 54(30.7) 122(69.3)
Parity 0.21
≤1 55(25.1) 164(74.9)
≥2 62(34.3) 119(65.7)
Marital status 0.37
Married 96(27.7) 250(72.3)
Not married 15(27.8) 39(72.2)
Educational Status 0.01
Educated 95(26.1) 270(73.9)
Not Educated 16(45.7) 19(54.3)
Employment status 0.15
Employed 104(28.8) 257(71.2)
Unemployed 9(23.1) 30(76.9)
Gestational Age at 1st ANC visit 0.06
Early (1st&2nd trim) 103(27.1) 277(72.9)
Late (3rd trim) 10(50.0) 10(50.0)
Number of ANC Visits <0.01
≥ 4Visits 102(26.7) 280(73.3)
<4 visits 14(77.8) 4(22.2)
Knowledge of IPTp 0.01
Good (>50%) 52(23.2) 172(76.8)
Poor (≤50%) 64(36.4) 112(63.6)
Knowledge of MiP 0.03
Good (>50%) 95(26.4) 265(73.6)
Poor (≤50%) 15(37.5) 25(62.5)

SP= Sulphadoxine-Pyrimethamine, ANC=antenatal care